Latest Pharma News Update... Aug 31
Brukisa is indicated for the treatment of adult patients with Waldenström’s Macroglobulinemia ... Feb 19
EUSA Pharma, FDA approval of phase 3 clinical trial for Siltuximab in patients with COVID-19 associated Acute Respiratory Distress Syndrome ... Jul 03
-Advertisements-